Collegium Pharmaceutical
COLL
$36.42
Share price
1.62%
Change (1 day)
59.46%
Change (1 year)
Categories
Earnings for Collegium Pharmaceutical (COLL)
Earnings in 2023 (TTM): $0.15 B
According to Collegium Pharmaceutical 's latest financial reports the company's current earnings (TTM) are $0.15 B. In 2022 the company made an earning of $34.36 M an increase over its 2021 earnings that were of $17.64 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Collegium Pharmaceutical from 2014 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $0.15 B | 362.88% |
| 2022 | $34.36 M | 94.82% |
| 2021 | $17.64 M | -68.76% |
| 2020 | $56.46 M | -358.85% |
| 2019 | -$21.82 M | 14.82% |
| 2018 | -$19 M | -74.68% |
| 2017 | -$75.05 M | -20.23% |
| 2016 | -$94.09 M | 250.85% |
| 2015 | -$26.82 M | 51.81% |
| 2014 | -$17.67 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 United Therapeutics UTHR | $1.33 B | 738.36% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | -$13.05 M | -108.20% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $0.51 B | 222.21% | 🇮🇪 Ireland |
 KemPharm KMPH | -$41.91 M | -126.34% | 🇺🇸 USA |